Frank Howard, MD, PhD Assistant Professor, Medicine School of Medicine

Research & Grantsmanship 

  Abstracts Reporting Research -- Peer Reviewed

• Cary A. Presant, Linda Bosserman, Frank Howard and Brandon Emilio, Wilshire Oncology Medical Group, La Verne, California. Patterns of metastatic (met) disease sites in breast cancer (BrCa): implications for availability of fresh tumor tissue (FTT) for personalized BrCa treatment (Rx) planning (TP) in met disease. Submitted, Amer Soc Clin Oncol, 2008.   ( 0/2008 )

• C.A. Presant, L. Bosserman, C. Kelley, T. Young, M. Vakil, R. Horns, G. Upadhyaya, B. Ebrahimi, C. Yeon, F. Howard and A. Rios. Wilshire Oncology Medical Group, LaVerne, California. “Aromatase inhibitor (AI)-associated arthralgia (A) and bone pain (BP): frequency and characterization in community based clinical practice.” Proc Amer Soc Clin Onc and Poster Presentation, 2006.   ( 0/2006 )

• Pathogen Inactivated Platelets (plt) Using Helinx™ Technology (INCERCEPT plt) Are Hemostatically Effective in Thrombocytopenic Patients (tcp pts): The SPRINT Trial. J. McCullough, D. Vesole, R.J. Benjamin, S. Slichter, A. Pineda, E. Snyder, E. Stadtmauer, I. Lopez-Plaza, S. Coutre, R.G. Strauss, L.T. Godnough, J. Fridey, T. Raife, R. Cable, S. Murphy, F. Howard, K. Davis, A. Koutsoukos, L. Lin, P. Metzel, D.H. Bucholz, L. Corash, M.G. Conlan. Blood 98(11), 450a, 2001. Presented as an oral presentation at the 2001 Annual Meeting of the American Society of Hematology, Orlando, Florida, December 2001.   ( 12/2001 )

• Rapid monitoring of peripheral blood stem cell (PBSC) mobilization by using cell membrane phospholipid content correlates well with CD34+ measurements, successful harvest and engraftment. C-S Chen, Michael B Lilly, Fu-sheng Wang, Frank D Howard IV, Berend Houwen. Presented as a poster at the 42nd Annual Meeting of the American Society of Hematology, San Francisco, California, December 2000. ( 12/2000 )